当前位置: 首页 > 期刊 > 《世界中医药》 > 201811
编号:13581787
宫瘤消胶囊联合米非司酮治疗子宫肌瘤对患者子宫肌瘤体积及激素水平的影响(4)
http://www.100md.com 2018年6月1日 《世界中医药》 201811
     [12]费春香,吴江平,吴瑛,等.宫瘤消胶囊联合散结镇痛胶囊对子宫腺肌病患者月经量及痛经的影响[J].河北中医,2016,38(6):924-926.

    [13]Ekine A A,Lawani L O,Iyoke C A,et al.Review of the Clinical Presentation of Uterine Fibroid and the Effect of Therapeutic Intervention on Fertility[J].IEEE Electron Device Letters,2015,3(1):9-13.

    [14]Fa-zhi,Yi-teng,YUAN,et al.Using shapes correlation for active.contour segmentation of uterine fibroid ultrasound images in computer-aided therapy[J].Applied Mathematics:A Journal of Chinese Universities,2016,31(1):37-52.

    [15]殷捷,肖海娟.消癥汤联合米非司酮治疗气虚血瘀型子宫肌瘤临床观察[J].陕西中医,2017,38(10):1345-1346.

    [16]Brakta S,Diamond JS,Al-Hendy A,et al.Role of vitamin D in uterine fibroid biology[J].Fertil Steril,2015,104(3):698-706.

    [17]刘丽萍.米非司酮联合宫瘤消对子宫肌瘤患者细胞因子和性激素水平的影响[J].医学综述,2016,22(13):2646-2648,2649.

    [18]周庆玲.米非司酮联合宫瘤消胶囊治疗子宫肌瘤的临床疗效分析[J].中国妇幼保健,2017,32(7):1453-1455.

    [19]Yen HR,Chen YY,Huang TP,et al.Prescription patterns of Chinese herbal products for patients with uterine fibroid in Taiwan:A nationwide population-based study[J].J Ethnopharmacol,2015,171:223-230.

    [20]楊莉.调冲消癥方联合米非司酮治疗子宫肌瘤临床研究[J].中医学报,2017,32(7):1301-1304., 百拇医药(张生兰 马西文)
上一页1 2 3 4